Drug Approval | June 07, 2022
Zydus Lifesciences receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
The drug will be manufactured at the group’s topical facility at Ahmedabad
The drug will be manufactured at the group’s topical facility at Ahmedabad
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
The rally attracted around 250 riders, including professionals and amateurs.
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
AstraZeneca also played a critical role in the global response to COVID-19.
Subscribe To Our Newsletter & Stay Updated
